{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:00:59Z","timestamp":1772744459546,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s40257-016-0194-4","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T10:36:20Z","timestamp":1465468580000},"page":"421-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Insurance Coverage of Biologics for Moderate-to-Severe Psoriasis: A Retrospective, Observational 5-Year Chart Review"],"prefix":"10.1007","volume":"17","author":[{"given":"Mai","family":"Abdelnabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakash","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Rengifo-Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"issue":"4","key":"194_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D30WZ4H31B","volume":"15","author":"BA Yentzer","year":"2009","unstructured":"Yentzer BA, Yelverton CB, Simpson GL, Simpson JF, Hwang W, Balkrishnan R, et al. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis. Dermatol Online J. 2009;15(4):1.","journal-title":"Dermatol Online J"},{"key":"194_CR2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1377\/hlthaff.25.5.1205","volume":"25","author":"JC Robinson","year":"2006","unstructured":"Robinson JC. Insurer strategies for managing use of and cost of biopharmaceuticals. Health Aff. 2006;25:1205\u201317.","journal-title":"Health Aff"},{"issue":"12","key":"194_CR3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nbt1209-1082","volume":"27","author":"S Liang","year":"2009","unstructured":"Liang S, Haas JS, Phillips KA. Medicare formulary coverage for top-selling biologics. Nat Biotechnol. 2009;27(12):1082\u20134.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"194_CR4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1377\/hlthaff.25.5.1332","volume":"25","author":"CD Mullins","year":"2006","unstructured":"Mullins CD, Lavallee DC, Pradel FG, DeVries AR, Caputo N. Health plans\u2019 strategies for managing outpatient specialty pharmaceuticals. Health Aff (Millwood). 2006;25(5):1332\u20139.","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"194_CR5","first-page":"14","volume":"17","author":"CV Goff","year":"2008","unstructured":"Goff CV, Hoffman JC, Vogenberg R. Biologic therapy management: the need for value-based health benefits models. A peer-reviewed white paper by the Biologic Finance and Access Council. Manage Care. 2008;17(3):14\u201327.","journal-title":"Manage Care"},{"issue":"5","key":"194_CR6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1377\/hlthaff.25.5.1240","volume":"25","author":"J Bowman","year":"2006","unstructured":"Bowman J, Rousseau A, Silk D, Harrison C. Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006. Health Aff (Millwood). 2006;25(5):1240\u20138.","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"194_CR7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1176\/ps.2007.58.3.308","volume":"58","author":"HA Huskamp","year":"2007","unstructured":"Huskamp HA, Stevenson DG, Donohue JM, Newhouse JP, Keating NL. Coverage and prior authorization of psychotropic drugs under Medicare Part D. Psychiatr Serv. 2007;58(3):308\u201310.","journal-title":"Psychiatr Serv"},{"key":"194_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7573\/dic.212266","volume":"3","author":"J Cheng","year":"2014","unstructured":"Cheng J, Feldman SR. The cost of biologics for psoriasis is increasing. Drugs Context. 2014;3:212\u201366.","journal-title":"Drugs Context"},{"key":"194_CR9","unstructured":"National Association of Insurance Commissioners. http:\/\/www.naic.org . Accessed 28 Mar 2016."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-016-0194-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0194-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T09:56:11Z","timestamp":1656669371000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-016-0194-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1007\/s40257-016-0194-4","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}